For its third fiscal quarter (ending September 30), Penumbra Inc (NYSE: PEN) has reported a 217% increase in E.P.S. from $0.24 a year ago to $0.76 in the current quarter. E.P.S. were $0.89 for the […]
Intra-Cellular Therapies Inc (NASDAQ: ITCI) has reported a loss for its third fiscal quarter (ending September 30) of $-0.25 versus a loss $-0.25 for the same period a year ago — flat performance. For the […]
Blueprint Medicines Corp (NASDAQ: BPMC) has reported a loss for its third fiscal quarter (ending September 30) of $-0.89 versus a loss $-2.20 for the same period a year ago — a decline of -60%. […]
Vulcan Materials Co (NYSE: VMC) has reported earnings for its third fiscal quarter (ending September 30) of $1.58 versus $2.10 for the same period a year ago — a decline of -25%. E.P.S. were $6.44 […]
On 10/30/24, AtriCure Inc (NASDAQ: ATRC) stock enjoyed a major increase of 18.3%, closing at $34.83. Moreover, exceptionally high trading volume at 482% of normal accompanied the advance. The stock has been weak relative to […]
Omega Flex Inc (NASDAQ: OFLX) has reported earnings for its third fiscal quarter (ending September 30) of $0.46 versus $0.55 for the same period a year ago — a decline of -16%. For the latest […]
For its third fiscal quarter (ending September 30), AtriCure Inc (NASDAQ: ATRC) has reported a -15% decline in E.P.S. from $-0.20 a year ago to $-0.17 in the current quarter. For the latest four quarters […]
The Container Store Group Inc (NYSE: TCS) has reported a loss for its second fiscal quarter (ending September 30) of $-4.85 versus a loss $-0.48 for the same period a year ago — an increase […]
CVR Energy Inc (NYSE: CVI) stock closed at $18.06 on 10/29/24 after a major decline of -24.2%. Moreover, trading volume in this decline was exceptionally high at 716% of normal. The stock has declined -25.5% […]
Rambus Inc (NASDAQ: RMBS) stock closed at $51.00 on 10/29/24 after a major increase of 13.8%. Moreover, trading volume in this advance was exceptionally high at 203% of normal. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research